MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/20.06.25 Share Price

Warrant

DE000ME6VMS9

Market Closed - Börse Stuttgart 17:11:29 28/06/2024 BST
0.34 EUR -8.11% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/20.06.25
1 month+17.24%
3 months-54.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 0.34 -8.11%
27/06/24 0.37 +8.82%
26/06/24 0.34 +6.25%
25/06/24 0.32 -8.57%
24/06/24 0.35 +2.94%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 05:11 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME6VMS
ISINDE000ME6VMS9
Date issued 12/01/2024
Strike 500 $
Maturity 20/06/2025 (357 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.92
Lowest since issue 0.19
Spread 0.04
Spread %10.00%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus